2018
November 21st
November 24th
Vignette
International course

Proton therapy

The course aims to address the most recent progress in proton therapy from the multidisciplinary perspective of physics, biology and medicine.

Course in English
Registration deadline

Practical Informations

Practical Informations

---

Selection result
19 October 2018
There is no registration fee for this course
Place
Bâtiment de Biologie du Développement
11 Rue Pierre et Marie Curie
75005 Paris - France

Maximum Number of Participants

30 people

Number of Participants

30 participants.

Selection Criteria

Participants selection will be based on their application file which should include:
- A CV (max. 1 page)
- A brief description of their scientific topic / medical activity
- A short paragraph explaining their motivation to attend the course and their expectations

Speakers

Speakers

Claire ALAPETITE - Institut Curie (FR)
Stéphanie BOLLE - Institut Curie (FR)
Sylvie BONVALOT - Institut Curie (FR)
Valentin CALUGARU - Institut Curie (FR)
Ludovic DE MARZI - Institut Curie (FR)
Rémi DENDALE - Institut Curie (FR)
Vincent FAVAUDON - Institut Curie (FR)
Loic FEUVRET - Institut Curie (FR)
Jean-Marc FONTBONNE - FR
Farid GOUDJIL - Institut Curie (FR)
Joel HERAULT - Centre Antoine Lacassagne (FR)
Youlia KIROVA - Institut Curie (FR)
Sandrine LACOMBE - Institut Curie (FR)
Yolande LIEVENS - University Hospital Ghent (BE)
Tony LOMAX - PSI (CH)
Hamid MAMMAR - Institut Curie (FR)
Alejandro MAZAL - Institut Curie (FR)
Frédérique MEGNIN - Institut Curie (FR)
Samuel MEYRONEINC - Institut Curie (FR)
Catherine NAURAYE - Institut Curie (FR)
Isabelle PASQUIE - Institut Curie (FR)
Annalisa PATRIARCA - Institut Curie (FR)
Stephanie PEETERS - MAASTRO Clinic (NL)
Peter PESCHKE - DKFZ (DE)
Philip POORTMANS - Institut Curie (FR)
Frédéric POUZOULET - Institut Curie (FR)
Yolanda PREZADO - Institut Curie (FR)

Keynote speakers

This list of speakers may still change

Organizers

Rémi DENDALE - Institut Curie
Alejandro MAZAL - Institut Curie
Philip POORTMANS - Institut Curie

Supported by

Varian
IBA
 Particle Therapy Co-Operative Group